# Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF)

> **NCT02677701** · PHASE4 · COMPLETED · sponsor: **Seattle Children's Hospital** · enrollment: 119 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** azithromycin
- **DRUG:** placebo (for azithromycin)
- **DRUG:** inhaled tobramycin

## Key facts

- **NCT ID:** NCT02677701
- **Lead sponsor:** Seattle Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-21
- **Primary completion:** 2020-02-13
- **Final completion:** 2020-02-13
- **Target enrollment:** 119 (ACTUAL)
- **Last updated:** 2021-06-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02677701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02677701, "Testing the Effect of Adding Chronic Oral Azithromycin to Inhaled Tobramycin in People With Cystic Fibrosis (CF)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02677701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*